These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6454382)

  • 1. Piperacillin pharmacokinetics in subjects with chronic renal failure.
    Thompson MI; Russo ME; Matsen JM; Atkin-Thor E
    Antimicrob Agents Chemother; 1981 Mar; 19(3):450-3. PubMed ID: 6454382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.
    Francke EL; Appel GB; Neu HC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA; Meyers BR; Hirschman SZ; Srulevitch E
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin pharmacokinetics in pediatric patients.
    Wilson CB; Koup JR; Opheim KE; Adelman LA; Levy J; Stull TL; Clausen C; Smith AL
    Antimicrob Agents Chemother; 1982 Sep; 22(3):442-7. PubMed ID: 6215893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of piperacillin in subjects with various degrees of renal function.
    Welling PG; Craig WA; Bundtzen RW; Kwok FW; Gerber AU; Madsen PO
    Antimicrob Agents Chemother; 1983 Jun; 23(6):881-7. PubMed ID: 6225390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
    Meyers BR; Hirschman SZ; Strougo L; Srulevitch E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.
    Tjandramaga TB; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1978 Dec; 14(6):829-37. PubMed ID: 742871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure.
    De Schepper PJ; Tjandramaga TB; Mullie A; Verbesselt R; van Hecken A; Verberckmoes R; Verbist L
    J Antimicrob Chemother; 1982 Feb; 9 Suppl B():49-57. PubMed ID: 6460734
    [No Abstract]   [Full Text] [Related]  

  • 14. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
    Thompson MI; Russo ME; Saxon BJ; Atkin-Thor E; Matsen JM
    Antimicrob Agents Chemother; 1982 Feb; 21(2):268-73. PubMed ID: 6462107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenously administered piperacillin in preadolescent children.
    Thirumoorthi MC; Asmar BI; Buckley JA; Bollinger RO; Kauffman RE; Dajani AS
    J Pediatr; 1983 Jun; 102(6):941-6. PubMed ID: 6222169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of piperacillin dose on elimination kinetics in renal impairment.
    Aronoff GR; Sloan RS; Brier ME; Luft FC
    Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin pharmacokinetics in renal failure.
    Fillastre JP; Leroy A; Humbert G
    Antimicrob Agents Chemother; 1987 Feb; 31(2):156-60. PubMed ID: 3471179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin kinetics.
    Batra VK; Morrison JA; Lasseter KC; Joy VA
    Clin Pharmacol Ther; 1979 Jul; 26(1):41-53. PubMed ID: 445961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.